| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
|
| | 2-Naphthalenol, 5-chloro-4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]- Basic information |
| | 2-Naphthalenol, 5-chloro-4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]- Chemical Properties |
| density | 1.51±0.1 g/cm3(Predicted) | | pka | 7.92±0.40(Predicted) |
| | 2-Naphthalenol, 5-chloro-4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]- Usage And Synthesis |
| Uses | KRAS G12D inhibitor 5 is a KRAS G12D inhibitor for the potential research of pancreatic cancer. | | References | [1] Kargbo RB. Targeting KRAS G12D Mutant for the Potential Treatment of Pancreatic Cancer. ACS Med Chem Lett. 2021 Oct 19;12(11):1643-1645. DOI:10.1021/acsmedchemlett.1c00545 |
| | 2-Naphthalenol, 5-chloro-4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]- Preparation Products And Raw materials |
|